This lifetime economic analysis demonstrates vagal nerve blocking therapy to be a cost-effective alternative to conventional therapy in class 2 and 3 obesity patients.
Iris Lin, PhD
Advertisement
Articles by Iris Lin, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
How Often Do Health Insurers Deny Doctor-Recommended Care?
2
Cicada COVID-19 Variant FAQs: Symptoms, Risk, and Prevention
3
Acoramidis Shows Durable Benefit at 54 Months in ATTR-CM
4
Oz White House Briefing Touts Drug Savings and Fraud Cleanup, but Data Tell a Nuanced Story
5